The Epstein-Barr Virus-Encoded BILF1 Protein Modulates Immune Recognition of Endogenously Processed Antigen by Targeting Major Histocompatibility Complex Class I Molecules Trafficking on both the Exocytic and Endocytic Pathways

Despite triggering strong immune responses, Epstein-Barr virus (EBV) has colonized more than 90% of the adult human population. Successful persistence of EBV depends on the establishment of a balance between host immune responses and viral immune evasion. Here we have extended our studies on the EBV...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Zuo, Jianmin, Quinn, Laura L., Tamblyn, Jennifer, Thomas, Wendy A., Feederle, Regina, Delecluse, Henri-Jacques, Hislop, Andrew D., Rowe, Martin
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology (ASM) 2011
נושאים:
Pathogenesis and Immunity
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3028889/
https://ncbi.nlm.nih.gov/pubmed/21123379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01608-10
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים